1 active not recruiting, 1 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow BEACOPP regimen: new trials by email Literature Review of BEACOPP regimen trials Research Report on BEACOPP regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma bleomycin sulfate, filgrastim, pegfilgrastim - Lymphoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 552 | 2002-08-01 | 2025-08-05 |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma bleomycin sulfate, ABVD regimen, BEACOPP regimen - Lymphoma | Phase 3 | Active not recruiting | European Organisation for Research and Treatment of Cancer - EORTC | 1649 | 1998-10-01 | 2025-08-05 |
Hodgkin Disease (2) · Lymphoma (2)
European Organisation for Research and Treatment of Cancer - EORTC (2)
Belgium (2) · France (2) · Netherlands (2) · Poland (2) · Spain (2) · Australia (1) · Canada (1) · Croatia (1) · Czechia (1) · Hungary (1) · Italy (1) · New Zealand (1) · Portugal (1) · Slovakia (1) · Slovenia (1)
Anna Sureda (1) · Bengt Glimelius, MD (1) · Christian Gisselbrecht, MD (1) · Christophe Ferme (1) · David C. Linch (1) · David Ma, MD (1) · Devinder Gill, MD (1) · E.M. Noordijk, MD (1) · H. Eghbali, MD (1) · Jose Thomas, MD (1) · Marine Divine, MD (1) · Patrice P. Carde, MD (1) · Ralph M. Meyer, MD, FRCPC (1) · Thierry O. Philip, MD (1)
PMID 27114593, PMID 28601705, PMID 29229324, PMID 42848781
2004 (1)